Joinn Laboratories(China)Co.,Ltd. (SHA:603127)
China · Delayed Price · Currency is CNY 46.18
0.00 (0.00%)
Nov 11, 2026, 3:00 PM CST
SHA:603127 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 530.78 | 911.93 | 965.21 | 2,863 | 2,917 | 4,154 |
Short-Term Investments | 1,759 | 791.57 | 729.85 | 1,533 | 6.97 | - |
Trading Asset Securities | 2,008 | 1,718 | 1,396 | 373.35 | 408.47 | 680.98 |
Cash & Short-Term Investments | 4,297 | 3,422 | 3,091 | 4,770 | 3,332 | 4,835 |
Cash Growth | 26.70% | 10.70% | -35.19% | 43.14% | -31.08% | 782.97% |
Accounts Receivable | 337.9 | 332.51 | 340 | 340.06 | 340.1 | 214.51 |
Other Receivables | 5.06 | - | - | 11.51 | 14.73 | 5.83 |
Receivables | 342.96 | 332.51 | 340 | 351.57 | 354.83 | 220.34 |
Inventory | 1,952 | 1,412 | 1,479 | 1,863 | 387.35 | 700.59 |
Prepaid Expenses | - | 7.12 | 2.35 | 0.94 | - | 0.27 |
Other Current Assets | 119.75 | 88.53 | 119.12 | 136.62 | 1,854 | 58.21 |
Total Current Assets | 6,712 | 5,262 | 5,031 | 7,122 | 5,928 | 5,814 |
Property, Plant & Equipment | 2,377 | 1,732 | 1,502 | 1,548 | 2,022 | 779.12 |
Long-Term Investments | 807.11 | 2,222 | 2,307 | 797.98 | 2,146 | 1,536 |
Goodwill | 52.41 | 54.69 | 138.04 | 136.01 | 133.74 | 122.43 |
Other Intangible Assets | 278.51 | 285.05 | 298.51 | 292.38 | 50.44 | 137.19 |
Long-Term Deferred Tax Assets | 41.22 | 39.68 | 33.36 | 28.25 | 32.61 | 43.85 |
Long-Term Deferred Charges | 86.97 | 69.85 | 63.06 | 74.89 | - | 30.51 |
Other Long-Term Assets | 993.02 | 16.61 | 23.67 | 28.03 | 50.89 | 73.21 |
Total Assets | 11,348 | 9,682 | 9,396 | 10,027 | 10,364 | 8,537 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 83.33 | 73.96 | 50.22 | 43.32 | 127.31 | 53.64 |
Accrued Expenses | 68.43 | 119.75 | 105.11 | 108.6 | 135.97 | 78.11 |
Current Portion of Long-Term Debt | - | - | - | - | 3.53 | 4.54 |
Current Portion of Leases | 20.86 | 20.17 | 39.37 | 27.5 | 24.01 | 21.65 |
Current Income Taxes Payable | 30.93 | 16.65 | 21.52 | 41.35 | 59.2 | 21.86 |
Current Unearned Revenue | 1,597 | 854.24 | 827.16 | 1,152 | 1,295 | 972.21 |
Other Current Liabilities | 130.81 | 75.82 | 67.18 | 94.62 | 199.53 | 62.22 |
Total Current Liabilities | 1,932 | 1,161 | 1,111 | 1,467 | 1,844 | 1,214 |
Long-Term Debt | - | - | - | - | 3.28 | 4.94 |
Long-Term Leases | 16.23 | 1.42 | 21.6 | 41.92 | 56.89 | 64.19 |
Long-Term Unearned Revenue | 65.65 | 72.74 | 67.92 | 74.49 | 80.68 | 60.84 |
Long-Term Deferred Tax Liabilities | 168.4 | 121.81 | 116.88 | 162.34 | 188.24 | 48.43 |
Total Liabilities | 2,182 | 1,357 | 1,317 | 1,746 | 2,173 | 1,393 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 749.35 | 749.48 | 749.48 | 749.89 | 535.68 | 381.25 |
Additional Paid-In Capital | 5,223 | 5,238 | 5,238 | 5,267 | - | 5,544 |
Retained Earnings | 3,378 | 2,538 | 2,263 | 2,308 | 2,125 | 1,189 |
Treasury Stock | -198.33 | -230.57 | -220.56 | -146.45 | - | -3.93 |
Comprehensive Income & Other | 13.03 | 30.19 | 49.48 | 100.52 | 5,523 | 26.74 |
Total Common Equity | 9,166 | 8,325 | 8,079 | 8,279 | 8,184 | 7,136 |
Minority Interest | - | 0.37 | 0.37 | 1.72 | 7.17 | 8.22 |
Shareholders' Equity | 9,166 | 8,325 | 8,079 | 8,281 | 8,191 | 7,144 |
Total Liabilities & Equity | 11,348 | 9,682 | 9,396 | 10,027 | 10,364 | 8,537 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 37.09 | 21.6 | 60.97 | 69.42 | 87.71 | 95.32 |
Net Cash (Debt) | 4,260 | 3,400 | 3,030 | 4,700 | 3,245 | 4,740 |
Net Cash Growth | 26.78% | 12.21% | -35.53% | 44.87% | -31.55% | 806.03% |
Net Cash Per Share | 5.63 | 4.57 | 4.09 | 6.28 | 4.32 | 6.50 |
Filing Date Shares Outstanding | 736.21 | 777.34 | 619.45 | 743.27 | 749.95 | 747.24 |
Total Common Shares Outstanding | 736.21 | 777.34 | 619.45 | 743.27 | 749.95 | 747.24 |
Working Capital | 4,780 | 4,102 | 3,921 | 5,655 | 4,084 | 4,600 |
Book Value Per Share | 12.45 | 10.71 | 13.04 | 11.14 | 10.91 | 9.55 |
Tangible Book Value | 8,835 | 7,985 | 7,642 | 7,851 | 8,000 | 6,877 |
Tangible Book Value Per Share | 12.00 | 10.27 | 12.34 | 10.56 | 10.67 | 9.20 |
Buildings | - | 721.98 | 590.45 | 455.95 | - | 371.05 |
Machinery | - | 668.17 | 643.03 | 581.35 | 957.9 | 415.14 |
Construction In Progress | - | 280.42 | 368.93 | 342.01 | 277.74 | 127.36 |
Leasehold Improvements | - | - | - | - | 61.62 | - |
Order Backlog | - | 2,600 | - | - | - | - |